Patent Assignment
Reel/Frame 033805/0806
Assignment of Assignor's Interest
Recorded: 2014-09-24
Pages: 4
Assignor
NOVARTIS PHARMACEUTICALS UK LIMITED
Executed: 2012-06-04
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property
(1)
Use of a Pyrazole Derivative in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 24, 2014
From: FORD, PAUL ANDREW
To: NOVARTIS PHARMACEUTICALS UK LIMITED
Reel/Frame 033805/0767 →
Assignment of Assignor's Interest
Sep 30, 2015
From: NOVARTIS PHARMA AG
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 036695/0602 →
Assignment of Assignor's Interest
Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Security Interest
Aug 10, 2017
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 043523/0317 →
Change of Address
May 23, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 046223/0457 →
Security Interest
Nov 7, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047446/0556 →
Release of Security Interest
Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMINTED
Reel/Frame 055010/0654 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 55010 Frame: 654. Assignor(S) Hereby Confirms the Release of Security Interest .
Oct 29, 2024
From: KREOS CAPITAL V (UK) LIMITED
To: MEREP BIOPHARMA 1 LIMITED
Reel/Frame 069273/0237 →
Corrective Assignment to Correct the Spelling of the Receiving Party Data from Merep Biopharma I Limited to Mereo Biopharma 1 Limited Previously Recorded on Reel 69273 Frame 237. Assignor(S) Hereby Confirms the Corrective Assignment.
Apr 10, 2025
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 070808/0578 →